Andreas Plueckthun | Professor Of Biochemistry, Director, Department Of Biochemistry
University of Zurich

(ChatGPT): Andreas Plueckthun is a distinguished Professor of Biochemistry and the Director of the Department of Biochemistry at the University of Zurich. With a strong background in protein engineering and molecular biology, he is a renowned expert in the field of biologics. Dr. Plueckthun's research focuses on the development of novel therapeutic proteins and antibodies for various diseases, including cancer and autoimmune disorders.

Throughout his career, Dr. Plueckthun has made significant contributions to the field of biologics, particularly in the area of antibody engineering and protein design. His work has led to the development of innovative technologies for the optimization of biologics, improving their efficacy and safety profiles. He is also known for his pioneering research in the field of recombiant antibodies, novel scaffolds (the DARPin technology), and virus-like particles (the SHREAD technology), which all have the potential to revolutionize targeted therapy for a wide range of diseases. All of these have also led to several start-up companies that he co-founded

As a speaker at the Festival of Biologics Basel 2025, Europe's Largest Biologics Event, Dr. Plueckthun will share his insights and expertise with fellow researchers, industry professionals, and policymakers. His presentation is expected to provide valuable perspectives on the latest advancements in biologics research and development, as well as the future directions of the field.

Dr. Plueckthun's passion for scientific innovation and commitment to advancing biologics research make him a highly respected figure in the academic and industry communities. His contributions to the field have not only expanded our understanding of biologics but also paved the way for the development of new and improved therapies for patients worldwide.